GSK
GSK
GSK
893 hedge funds and large institutions have $13.5B invested in GSK in 2019 Q4 according to their latest regulatory filings, with 144 funds opening new positions, 295 increasing their positions, 287 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 804 → 893 (+89)
3% more repeat investments, than reductions
Existing positions increased: 295 | Existing positions reduced: 287
0.09% more ownership
Funds ownership: 4.53% → 4.62% (+0.09%)
Holders
893
Holding in Top 10
16
Calls
$163M
Puts
$128M
Top Buyers
| 1 | +$318M | |
| 2 | +$149M | |
| 3 | +$69.4M | |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$43M |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
+$39.5M |
Top Sellers
| 1 | -$91.5M | |
| 2 | -$61M | |
| 3 | -$34.5M | |
| 4 |
Jane Street
New York
|
-$33.8M |
| 5 |
BHC
Bowen Hanes & Co
Ponte Vedra Beach,
Florida
|
-$32.3M |